K C Rice|J M Cook - JoVE Visualize

Showing results (301-310 of 475) with videos related to

Pageof 48

Sort By:

Synapse (New York, N.Y.)|November 9, 2000

Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotoninR B Rothman, M H Baumann, C M Dersch, et al.

Nature Immunology|October 9, 2001

Corticotropin-releasing hormone promotes blastocyst implantation and early maternal toleranceA Makrigiannakis, E Zoumakis, S Kalantaridou, et al.

Neuroendocrinology|May 1, 1990

Anti-opioid receptor antibody recognition of a binding site on brain and leukocyte opioid receptorsD J Carr, B R DeCosta, C H Kim, et al.

Drug and Alcohol Dependence|March 1, 1991

The partial opioid agonist, buprenorphine, protects against lethal effects of cocaineJ M Witkin, R E Johnson, J H Jaffe, et al.

Journal of Medicinal Chemistry|May 10, 1996

(Aminoalkyl)indole isothiocyanates as potential electrophilic affinity ligands for the brain cannabinoid receptorK Yamada, K C Rice, J L Flippen-Anderson, et al.

Neurochemical Research|September 1, 1994

Dihydrocodeinone-hydrazone, dihydrocodeinone-oxime, naloxone-3-OMe-oxime, and clocinnamox fail to irreversibly inhibit opioid kappa receptor bindingQ Ni, H Xu, J S Partilla, et al.

Synapse (New York, N.Y.)|November 9, 2000

Opioid peptide receptor studies. 14. Stereochemistry determines agonist efficacy and intrinsic efficacy in the [(35)S]GTP-gamma-S functional binding assayH Xu, A Hashimoto, K C Rice, et al.

European Journal of Pharmacology|August 29, 1989

Pharmacological activities of optically pure enantiomers of the kappa opioid agonist, U50,488, and its cis diastereomer: evidence for three kappa receptor subtypesR B Rothman, C P France, V Bykov, et al.

Journal of Medicinal Chemistry|June 1, 1986

Probes for narcotic receptor mediated phenomena. 12. cis-(+)-3-Methylfentanyl isothiocyanate, a potent site-directed acylating agent for delta opioid receptors. Synthesis, absolute configuration, and receptor enantioselectivityT R Burke, A E Jacobson, K C Rice, et al.

FEBS Letters|July 17, 1989

Synthesis and evaluation of optically pure [3H]-(+)-pentazocine, a highly potent and selective radioligand for sigma receptorsB R de Costa, W D Bowen, S B Hellewell, et al.

Pageof 48

Showing results (301-310 of 475) with videos related to

Sort By:

Pageof 48

Synapse (New York, N.Y.)|November 9, 2000

Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotoninR B Rothman, M H Baumann, C M Dersch, et al.

Nature Immunology|October 9, 2001

Corticotropin-releasing hormone promotes blastocyst implantation and early maternal toleranceA Makrigiannakis, E Zoumakis, S Kalantaridou, et al.

Neuroendocrinology|May 1, 1990

Anti-opioid receptor antibody recognition of a binding site on brain and leukocyte opioid receptorsD J Carr, B R DeCosta, C H Kim, et al.

Drug and Alcohol Dependence|March 1, 1991

The partial opioid agonist, buprenorphine, protects against lethal effects of cocaineJ M Witkin, R E Johnson, J H Jaffe, et al.

Journal of Medicinal Chemistry|May 10, 1996

(Aminoalkyl)indole isothiocyanates as potential electrophilic affinity ligands for the brain cannabinoid receptorK Yamada, K C Rice, J L Flippen-Anderson, et al.

Neurochemical Research|September 1, 1994

Dihydrocodeinone-hydrazone, dihydrocodeinone-oxime, naloxone-3-OMe-oxime, and clocinnamox fail to irreversibly inhibit opioid kappa receptor bindingQ Ni, H Xu, J S Partilla, et al.

Synapse (New York, N.Y.)|November 9, 2000

Opioid peptide receptor studies. 14. Stereochemistry determines agonist efficacy and intrinsic efficacy in the [(35)S]GTP-gamma-S functional binding assayH Xu, A Hashimoto, K C Rice, et al.

European Journal of Pharmacology|August 29, 1989

Pharmacological activities of optically pure enantiomers of the kappa opioid agonist, U50,488, and its cis diastereomer: evidence for three kappa receptor subtypesR B Rothman, C P France, V Bykov, et al.

Journal of Medicinal Chemistry|June 1, 1986

Probes for narcotic receptor mediated phenomena. 12. cis-(+)-3-Methylfentanyl isothiocyanate, a potent site-directed acylating agent for delta opioid receptors. Synthesis, absolute configuration, and receptor enantioselectivityT R Burke, A E Jacobson, K C Rice, et al.

FEBS Letters|July 17, 1989

Synthesis and evaluation of optically pure [3H]-(+)-pentazocine, a highly potent and selective radioligand for sigma receptorsB R de Costa, W D Bowen, S B Hellewell, et al.

Pageof 48